Curis, Inc. (NASDAQ:CRIS) Q2 2023 Earnings Conference Call August 3, 2023 4:30 PM ET Company Participants Jim Dentzer – President and Chief Executive Officer Soumit Roy – Jones Trading Operator I would now like to turn the conference over to Diantha Duvall, CurisÂ' Chief Financial Officer. Ms. Diantha, please go ahead. Thank you, and welcome to CurisÂ' second quarter 2023 business update call. Before we begin, I would like to encourage everyone to go to the Investors section of our website at www.curis.com ...

Condensed Consolidated Statements of Stockholders' Equity (In thousands, except share data) (Unaudited) | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | |-------------------------------------------------------------------|--------------------------------|-----------|------------------|-------|------------------------------------------|-------|-------|-----------------------------------|------------|----------------------------------------------------|-------|------------------ ...

General and administrative expenses were $4.8 million for the first quarter of 2023 as compared to $5.7 million for the same period in 2022. The decrease in general administrative expenses was driven primarily by lower employee related costs due to reduction in headcount. For the first quarter of 2023, other income net was $0.1 million as compared to other expense net of 1 million for the same period in 2022. Other income expense net primarily consists of interest income partially offset by expense related ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 000-30347 CURIS, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 04-3505116 (State or Other Jurisdiction of ...

Curis, Inc. (NASDAQ:CRIS) Q4 2022 Earnings Conference Call March 13, 2023 8:30 AM ET Conference Call Participants Operator Diantha Duvall James Dentzer We've also made important progress in our work to resolve the partial clinical hold on our leukemia study. In last quarter's call, we announced that the FDA had approved the reopening of our clinical sites so that we could enroll nine additional patients at the 200-milligram dose level to facilitate discussions with FDA on the Recommended Phase 2 Dose or RP2 ...

| --- | --- | --- | --- | --- | |------------------------------------------------|-------|-------|-------|-------| | (in thousands) \nAssets: | 2022 | | | 2021 | | Operating lease right-of-use asset | $ | 4,401 | $ | 5,749 | | | | | | | | Liabilities: | | | | | | Operating lease liability - short-term | $ | 1,141 | $ | 682 | | Operating lease liability - long-term | $ | 2,800 | $ | 4,358 | | Total operating liability | $ | 3,941 | $ | 5,040 | | --- | --- | --- | --- | --- | |-------------------------------- ...

Curis, Inc. (NASDAQ:CRIS) Q3 2022 Earnings Conference Call November 9, 2022 4:30 PM ET Company Participants Craig West – Vice President-Investor Relations and Corporate Communications Jim Dentzer – President and Chief Executive Officer Diantha Duvall – Chief Financial Officer Conference Call Participants Ed White – H.C. Wainwright Soumit Roy – Jones Research Li Watsek – Cantor Fitzgerald Operator Good afternoon, and welcome to Curis' Third Quarter 2022 Business Update Call. All participants will be in liste ...

Table of Contents Title of each class Trading Symbol Name of each exchange on which registered UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 000-30347 CURIS, INC. (Exact N ...

Corporate Presentation NASDAQ: CRIS Cautionary Note Regarding Forward Looking Statements This presentation contains certain forward-looking statements about Curis, Inc. ("we," "us," or the "Company") within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Words such as "expect(s)," "believe(s)," "will," "may," "anticipate(s)," "focus(es)," "plans," "mission," "strategy," "potential," "estimate(s)", "intend," "project," "seek," "should," "would" and similar expressions are int ...

Curis, Inc. (NASDAQ:CRIS) Q2 2022 Earnings Conference Call August 4, 2022 4:30 PM ET Company Participants Craig West - VP, IR & Corporate Communications Jim Dentzer - President & CEO Bill Steinkrauss - CFO & Chief Administrative Officer Conference Call Participants Soumit Roy - JonesResearch Li Watsek - Cantor Fitzgerald Bob Martell - Head, Research and Development Operator Good afternoon, everyone, and welcome to Curis' second quarter 2022 earnings conference call. [Operator instructions] At this time, I'd ...